Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Disorders of Consciousness
2024-518433-29-00Phase 2Suspended
- Sponsor
- University of Liège
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in disorder of consciousness (DOC) and traumatic brain injury (TBI) comparing Ketalar with Placebo (2 arms). Primary endpoints: New signs of consciousness and Brain complexity (LZC/PCI). Started Oct 2024; status: suspended.
02
Drugs
ketamine
03
Conditions
disorder of consciousness (DOC)traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2024-518433-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518433-29-00.